A questionnaire-based study to assess the status and perspective of fixed-dose combination among the various stakeholders including regulators, clinicians, researchers, and industry

• Asıl Yazarlar: Krishan Kumar Bhardwaj (Yazar), K Bangarurajan (Yazar), Tanveer Naved (Yazar), Satyendra Kumar Rajput (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Fixed-dose combinations (FDCs) dominating the global market because of better compliance. However, irrational combination can lead to human-made menace in terms of development of resistance, tolerance, drug abuse, and economy encumbrance. The US Food and Drug Administration defines a combination pro...